Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhongyu Yuan"'
Autor:
Hanfang Jiang, Quchang Ouyang, Yongmei Yin, Zhongshen Tong, Kunwei Shen, Zhongyu Yuan, Cuizhi Geng, Yaxin Liu, Guohong Song, Ran Ran, Wei Li, Qing Qu, Meiyu Wang, Luping Meng, Youzhi Tong, Huiping Li
Publikováno v:
European Journal of Cancer. 176:1-12
Proxalutamide is a novel second-generation non-steroidal androgen receptor (AR) antagonist. This study aimed to evaluate the preliminary efficacy and safety of proxalutamide in patients with AR-positive metastatic breast cancer (ARIn this open-label,
Autor:
Jiaxuan Peng, Wei Wang, Qiaowei Song, Jie Hou, Hui Jin, Xue Qin, Zhongyu Yuan, Yuguo Wei, Zhenyu Shu
Publikováno v:
Academic Radiology.
Autor:
Yongfu Wu, Ning Zhang, Yan Shi, Zetao Chen, Han Zhang, Jiaqiang Yin, Tao Zeng, Zhongyu Yuan, Ni Li, Yibin Ren, Liqun Cai, Yunzhao Li, Shengzhong Du
Publikováno v:
SSRN Electronic Journal.
Autor:
Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Meiting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Xin An
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Neurobiology of Stress, Vol 15, Iss, Pp 100333-(2021)
Neurobiology of Stress
Neurobiology of Stress
Early exposure to stressful and adverse life events at fetal and neonatal stages is one of crucial risk factors for mood disorders such as anxiety and depressive disorder in adulthood. Intergenerational effects of prenatal stress on offspring are sti
Autor:
Huiping Li, Yongmei Yin, Xiao Jia Wang, Zhongyu Yuan, Cuizhi Geng, Pin Zhang, Xichun Hu, Yongsheng Wang, Jing Cheng, Binghe Xu, Rou-Jun Peng, Zefei Jiang, Qingyuan Zhang, Jian Liu, Baochun Zhang, Zhongsheng Tong, Shude Cui, Shaohua Zhang, Hongming Pan, Hong Zheng, Li Tang, Tao Sun, Yuee Teng, Qiang Yao, Jian Huang, Min Yan, Jinsong Lu, Rongguo Qiu, Junlan Yang, Ping Sun
Publikováno v:
The Lancet Oncology. 18:371-383
Utidelone, a genetically engineered epothilone analogue, has shown promise as a potential treatment for breast cancer in phase 1 and 2 trials. The aim of this phase 3 trial was to compare the efficacy and safety of utidelone plus capecitabine versus
Autor:
Kaping Lee, Yan Xia Shi, Wen Xia, Qiufan Zheng, S. Wang, Fei Xu, Zhongyu Yuan, Y. Zeng, M.T. Kong, Ge Qin, Ruoxi Hong, Qianyi Lu, Tao Qin, Kai Zhang
Publikováno v:
Annals of Oncology. 28:v29-v30
Autor:
Huijuan Qiu, Feifei Zhou, Chenxi Yin, Liangping Xia, Guifang Guo, Fang Wang, Xuxian Chen, Yuming Rong, Zhongyu Yuan, Xi Wang, Wenzhuo He
Publikováno v:
Clinical Breast Cancer. 12:404-411
Background The lymph node ratio (LNR) classification has shown superiority to pN staging (the number of positive lymph nodes) in breast cancers, but it has not been examined according to whether sufficient lymph nodes have been dissected. Methods All